Encompass Health Q3 2026: revenue hits $1.61B, EPS rises 21% to $1.5

what happened

The rehabilitation hospital operator booked $1.61 billion in revenue for Q3 2026, 8.9% above the prior-year quarter. Net income climbed 16.6% to $203.6 million, and diluted earnings per share rose 21% to $1.5. TradingView, summarizing the company's 10-Q filing with the SEC, published these figures.

Higher patient volumes and pricing drove most of the gain. Discharges rose 5.7% in the quarter and 3.0% on a same-store basis. Medicare's share of revenue increased to 66.3% from 64.1%, while Medicare Advantage slipped to 15.7% from 16.6%. In the first nine months of 2026 the company opened four rehabilitation hospitals and added 85 beds at existing sites, with more hospitals and bed additions planned through 2027.

The figures come from an AI-generated summary of the filing.

why it matters

For investors the picture is broadly positive: revenue and profit are growing on the back of more patients and higher prices, and management expects aging demographics to keep demand firm over the long term. Because the summary is AI-generated and may contain errors, key figures should be checked against the original filing.

market impact

Encompass Health shares: revenue and profit growth supports the stock

• ▲Encompass Health shares pressure up — revenue and profit growth on higher patient volumes and pricing

tags

instruments